---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-013491"
form_type: "8-K"
ticker: "BFRI"
cik: "0001858685"
company_name: "Biofrontera Inc."
filed_at: "2025-06-03T23:59:59+00:00"
generated_at: "2026-05-20T01:57:45.198110+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Biofrontera supplements proxy statement reclassifying two proposals as routine matters for broker voting

## Summary
- NYSE determined Proposal Nos. 2 and 3 are routine; brokers may vote without instructions, reversing earlier disclosure.
- Proposal No. 2 increases authorized common shares from 35M to 70M; Proposal No. 3 is an adjournment measure.
- Proxies already received remain valid unless revoked; annual meeting still set for June 12, 2025.
- Only Proposal No. 4 (ratification of auditor) was previously listed as routine in the original proxy statement.

## SEC filing metadata
- accession: 0001641172-25-013491
- form_type: 8-K
- ticker: BFRI
- cik: 0001858685
- company_name: Biofrontera Inc.
- filed_at: 2025-06-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1858685/000164117225013491/0001641172-25-013491-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1858685/000164117225013491/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-013491
- JSON: https://secwatch.observer/filing/0001641172-25-013491.json
- Plain text: https://secwatch.observer/filing/0001641172-25-013491.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.